Arrowhead Pharmaceuticals
ARWR
#2100
Rank
$9.69 B
Marketcap
$69.25
Share price
-0.37%
Change (1 day)
473.26%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) Fails to deliver data

Key failure to deliver metrics for Arrowhead Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Arrowhead Pharmaceuticals (ARWR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Arrowhead Pharmaceuticals (ARWR) - since 2016

Volume in USD (price x number of shares), data since 2016

Arrowhead Pharmaceuticals (ARWR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$7.22 M-25.58%
2025$9.71 M-0.81%
2024$9.79 M55.71%
2023$6.28 M39.55%
2022$4.5 M-73.07%
2021$16.73 M-49.26%
2020$32.99 M-52.98%
2019$70.16 M188.2%
2018$24.34 M233.16%
2017$7.3 M-4.53%
2016$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$78.35 M$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
$0.11 B$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$5.24 M$14.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$8.14 M$40.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
$0.75 M$9.77 M๐Ÿ‡บ๐Ÿ‡ธ USA